WeVote
Log In

Bill

Bill

AB 2000

Drug formularies.

2025-2026 Regular Session Introduced by Cecilia Aguiar-Curry

AB 2000 initiates legislative action on California prescription drug policy, currently entering formal review with details on specific reforms pending disclosure as the bill develops.

Re-referred to Com. on HEALTH.
#drugformularies
0
WeVote Research Nonpartisan
Bill Summary · AB 2000

Legislative bill overview

AB 2000 has been introduced in the California legislature and is currently in early stages of processing (first reading). The bill addresses prescription drugs, though specific provisions are not yet publicly detailed given its very early status in the legislative process.

Why this is important

Prescription drug costs and access remain significant policy concerns in California, affecting healthcare affordability for millions of residents. Any legislative action on this topic has potential consequences for consumers, pharmaceutical manufacturers, insurance companies, and the state healthcare system.

Potential points of contention

  • Drug pricing mechanisms - whether the bill implements price controls, negotiation requirements, or transparency measures, which manufacturers argue may reduce investment in new drugs
  • Insurance coverage and access - provisions affecting which drugs insurers must cover or how patients access medications could benefit some groups while disadvantaging others
  • State vs. federal authority - California's regulatory scope relative to federal FDA authority and interstate commerce considerations

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.